Table 2 Demographics of patients who underwent BAL and/or EBC collection.

From: The role of oxidised self-lipids and alveolar macrophage CD1b expression in COPD

Patient group

Number

Age

FEV1

FEV1/FVC

Never-smoker control

35

53 (21–72)

100 (78–134)

84 (66–93)

Smoker

23

52 (24–67)

88 (74–112)

73 (61–87)

Ex-smoker

12

58 (29–74)

101 (85–123)

77 (71–89)

COPD smoker

46

58 (34–91)

68.5 (38–102)

61 (28–76)

COPD ex-smoker

51

68.5 (45–85)

63 (21–89)

58.5 (34–83)

  1. Data represents the median and the min and max of all patients in each group. Not all patients were used for each experiment. FEV1 data is presented as percentage of predicted values.
Back to article page